High materiality7/10
Seaport Therapeutics initiated with a Buy at Canaccord
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Analyst target update: Canaccord Genuity initiates Buy on SPTX; target $28; current price is $16.08.
- Canaccord initiates Buy on SPTX; target $28; price $16.08.
Key facts
- 01
Target: $28
- 02
Posted price: $16.08
- 03
Analyst firm: Seaport Global
- 04
Analyst: Sumant Kulkarni
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.